Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017)

Clin Transl Allergy · 2017 · PMC5576386

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although the results of the secondary endpoints showed a clear trend towards superior efficacy, BNO 1016 was not superior over placebo regarding the primary endpoint.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.